Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2004 Finding the Balance in Shared Decision Making, Commentary 2 Daniel A. Beals, MD Physicians need to manage parental treatment decisions when the decisions conflict with medical judgment. Virtual Mentor. 2004;6(2):89-91. doi: 10.1001/virtualmentor.2004.6.2.ccas3-0402. Policy Forum Aug 2003 The Ethics of Research with Children Timothy F. Murphy, PhD Using children as research subjects is only ethical in very specific situations where the risk to the child is minimal. Virtual Mentor. 2003;5(8):333-335. doi: 10.1001/virtualmentor.2003.5.8.pfor2-0308. Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 1 Brintha Krishnamoorthy Physicians have an ethical obligation to admit mistakes to their patients, even if no harm came of the mistakes. Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403. Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 2 Kevin O'Rourke, OP Physicians have an ethical obligation to admit mistakes to their patients, even if no harm came of the mistakes. Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403. In the Literature May 2004 Human Subjects Research for Biochemical Antidotes Susanna Smith A journal author believes human subjects should be used in research on biochemical weapons or their antidotes. Virtual Mentor. 2004;6(5):211-214. doi: 10.1001/virtualmentor.2004.6.5.jdsc1-0405. State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411. Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Pagination First page « First Previous page ‹ Previous … Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Page 25 Next page Next › Last page Last »
Case and Commentary Feb 2004 Finding the Balance in Shared Decision Making, Commentary 2 Daniel A. Beals, MD Physicians need to manage parental treatment decisions when the decisions conflict with medical judgment. Virtual Mentor. 2004;6(2):89-91. doi: 10.1001/virtualmentor.2004.6.2.ccas3-0402.
Policy Forum Aug 2003 The Ethics of Research with Children Timothy F. Murphy, PhD Using children as research subjects is only ethical in very specific situations where the risk to the child is minimal. Virtual Mentor. 2003;5(8):333-335. doi: 10.1001/virtualmentor.2003.5.8.pfor2-0308.
Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 1 Brintha Krishnamoorthy Physicians have an ethical obligation to admit mistakes to their patients, even if no harm came of the mistakes. Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403.
Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 2 Kevin O'Rourke, OP Physicians have an ethical obligation to admit mistakes to their patients, even if no harm came of the mistakes. Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403.
In the Literature May 2004 Human Subjects Research for Biochemical Antidotes Susanna Smith A journal author believes human subjects should be used in research on biochemical weapons or their antidotes. Virtual Mentor. 2004;6(5):211-214. doi: 10.1001/virtualmentor.2004.6.5.jdsc1-0405.
State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Many ethical and legal issues arise when academic medical research is sponsored by pharmaceutical companies. Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411.
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.